Spacex Just Fell Below a Key Level: Lockup Implications
SpaceX has experienced a sharp move after going public, sparking questions about lockups and what it means for future...
Stock Market
This page features valuable insights into the Stock Market, covering topics like tariffs and dividend investing. Stay informed to enhance your investment strategies.
3,082 articlesWhat $722,000 TransMedics Insider Sale Signals Investors
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
What This $114,000 Healthcare Insider Sale Signals
A director at AMN Healthcare recently disclosed selling about 3,681 shares for roughly $114,000 as the stock jumped 4...
Why Home Stock Jumped Today: The Major Drivers and Signals
Investing in homebuilders can be fast-moving. This article explains why a home stock jumped today, the catalysts behi...
Stock Market Today, June: Wendy's Meme Rally and CFO Change
Wendy’s stock is making waves as the latest meme-driven rally, paired with a key leadership shift. This article break...
Stock Market Today, June: Amazon Gains on Prime Day Demand
Investors dig into a mixed session as Amazon leads gains on Prime Day momentum and AI shopping activity. This guide b...
Warren Buffett's Favorite Holdings: 3 Stocks to Own Forever
Buffett built Berkshire Hathaway on a simple idea: invest in durable businesses and hold them. Here are three of his ...
Prediction: SpaceX Will Reach a July Price Milestone
A thoughtful look at what a July price milestone could mean for SpaceX in a hypothetical IPO scenario. Learn how to a...
This Infrastructure Stock Last Year Surged 14X: What Investors Learn
A little-known AI infrastructure stock last year exploded 14x, shaking up investors who focus on AI chips. This artic...
Coinbase Could Jump Higher as Crypto Recovery Unfolds
A broad crypto rebound is lifting Coinbase as the company pivots toward subscriptions and services. Analysts see upsi...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Intel 570% Past Year: Buy the Comeback or Take Profits?
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...